The cascade of care for Australians living with chronic hepatitis B: measuring access to diagnosis, management and treatment.

Conclusions: This analysis reveals substantial gaps in the cascade of care for CHB in Australia, most notably in diagnosis (with 43% undiagnosed) and in recommended yearly monitoring (87% not in care). The number receiving therapy represents only one-third of those estimated to require treatment to prevent progressive liver disease and liver cancer. Implications: These findings demonstrate that the majority of those affected are not receiving guideline-based care; highlight the need for improvements in opportunistic screening, engagement in care, and access to therapy; and provide a method to assess the impact of public health and clinical interventions in response to CHB over time. PMID: 25716519 [PubMed - as supplied by publisher]
Source: Australian and New Zealand Journal of Public Health - Category: Global & Universal Authors: Tags: Aust N Z J Public Health Source Type: research